Hence, taken together, we believe that high expression of C12orf48 could be a prognostic marker in cancer cells, and knockdown of C12orf48 might be a solution to attenuate the ability of PARP1 and preserve genomic stability. The gene discussed is PARPBP; the disease is cancer.